RJ
Rishab Jaiswal
About Rishab Jaiswal
Data last updated:
Rishab Jaiswal is a Director at Tempest Pharmaceuticals Private Limited (since 2023), Director at Calandium Sales Private Limited (since 2023) and Director at Ranbaxy Niryat Pvt. Ltd (since 2023), and holds 10 more current directorships. The companies operate in Chemicals, Financial Services and Business Outsourcing. The 13 current companies with reported revenue have a combined latest revenue of ₹72.5 Lakh; the largest is Tempest Pharmaceuticals Private Limited at ₹9.7 Lakh (FY 2025). Earlier, Rishab Jaiswal was a Director at Annpurna Investments Consultants Private Limited (2023–2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Tempest Pharmaceuticals Private Limited U24232WB2007PTC116075 | Director | 10 Jun 2023 | 2007 | ₹9.7 Lakh (FY 2025) | Active |
| Calandium Sales Private Limited U51909WB2010PTC144388 | Director | 15 Jun 2023 | 2010 | ₹8.4 Lakh (FY 2025) | Active |
| Ranbaxy Niryat Pvt. Ltd U51109WB1994PTC062376 | Director | 15 Jun 2023 | 1994 | ₹7.9 Lakh (FY 2025) | Active |
| Link Barter Private Limited U52190WB2009PTC140504 | Director | 15 Jun 2023 | 2009 | ₹7.9 Lakh (FY 2025) | Active |
| Supreme Dealtrade Private Limited U51909WB2010PTC142615 | Director | 15 Jun 2023 | 2010 | ₹7.8 Lakh (FY 2025) | Active |
| Moonstar Corporate Consultants Pvt Ltd U51109WB1996PTC078093 | Director | 15 Jun 2023 | 1996 | ₹7.2 Lakh (FY 2025) | Active |
| Hibiscus Mercantile Private Limited U51101WB2010PTC144397 | Director | 15 Jun 2023 | 2010 | ₹6.9 Lakh (FY 2025) | Active |
| Sars Surya Construction Private Limited U45400WB2007PTC116542 | Director | 10 Jun 2023 | 2007 | ₹5.6 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Annpurna Investments Consultants Private Limited U51909WB2009PTC138520 | Director | 01 Sep 2023 | 2009 | ₹10.2 Lakh (FY 2022) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rishab Jaiswal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Buddhadeb Chakraborty | 10165203 | Tempest Pharmaceuticals Private Limited , Sars Surya Construction Private Limited and 5 more | Director |
| Chanchal Kumar Mondal | 08483728 | Calandium Sales Private Limited , Ranbaxy Niryat Pvt. Ltd and 4 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rishab Jaiswal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rishab Jaiswal
Rishab Jaiswal currently holds 13 directorships: Tempest Pharmaceuticals Private Limited (Director, since 10 Jun 2023, revenue ₹9.7 Lakh (FY 2025)); Calandium Sales Private Limited (Director, since 15 Jun 2023, revenue ₹8.4 Lakh (FY 2025)); Ranbaxy Niryat Pvt. Ltd (Director, since 15 Jun 2023, revenue ₹7.9 Lakh (FY 2025)); Link Barter Private Limited (Director, since 15 Jun 2023, revenue ₹7.9 Lakh (FY 2025)); Supreme Dealtrade Private Limited (Director, since 15 Jun 2023, revenue ₹7.8 Lakh (FY 2025)); and 8 more.
Rishab Jaiswal was first appointed on 10 Jun 2023 as Director at Tempest Pharmaceuticals Private Limited.
The 13 current companies of Rishab Jaiswal that report revenue have a combined latest revenue of ₹72.5 Lakh: Tempest Pharmaceuticals Private Limited ₹9.7 Lakh (FY 2025); Calandium Sales Private Limited ₹8.4 Lakh (FY 2025); Ranbaxy Niryat Pvt. Ltd ₹7.9 Lakh (FY 2025); Link Barter Private Limited ₹7.9 Lakh (FY 2025); Supreme Dealtrade Private Limited ₹7.8 Lakh (FY 2025); and 8 more.
Rishab Jaiswal held 1 earlier board appointment: Annpurna Investments Consultants Private Limited (Director, 01 Sep 2023 to 30 Apr 2024).
The current boards of Rishab Jaiswal's companies include Buddhadeb Chakraborty (Tempest Pharmaceuticals Private Limited), Chanchal Kumar Mondal (Calandium Sales Private Limited).